Behind the desk, the pharmacist does not hide his surprise. “It’s on prescription, available quickly, but very expensive…” he slips when asked about the possibility of receiving a vaccine against the respiratory syncytial virus (RSV) for the elderly. Allow at least 250 euros, entirely at our expense. To have easier access, you will have to wait until October 2024 at the earliest, according to the schedule revealed in mid-September by the High Authority for Health (HAS). Too late, say around sixty doctors in a column that we publish. “There is no reason to wait, the time to act is now!” » they thunder. “We could have avoided several hundred or even a few thousand deaths this winter! » adds its initiator, Jérôme Barrière, oncologist in Cagnes-sur-Mer (Alpes-Maritimes).